U
USA Today News source @usatoday.com · McLean, Virginia 🇺🇸· 4w

#HeartHealth #Hypertension #CholesterolManagement

Link Preview
www.usatoday.com
30 or older? Major heart orgs now recommend you get this screening test
The American Heart Association and the American College of Cardiology have guidelines to help manage blood pressure and reduce hypertension-related risks.
Avatar
NPR News source @npr.org · Washington (state) 🇺🇸· 4w

#Hypertension #HealthTips #BloodPressureMonitoring

Link Preview
www.npr.org
I'm concerned about my blood pressure. Can I check it at home?
Do you have a medical question you'd like to get a doctor's honest answer to. Dr. Mara Gordon, a family physician in Camden, N.
Avatar
CBS News News source @cbsnews.com · New York 🇺🇸· Jan 31

#HeartHealth #HypertensionAwareness #PublicSafety

Link Preview
www.cbsnews.com
A police officer thought he had a muscle cramp. He ended up fighting for his life.
Kerry Breen is a news editor at CBSNews. com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital.
Avatar
Medscape News source @medscape.com · New York 🇺🇸· Jan 5

#Diabetes #Hypertension #CardiovascularHealth

Link Preview
www.medscape.com
Early Hypertension Linked to a Poorer Prognosis in T2D
In patients with type 2 diabetes (T2D), both young-onset hypertension (onset before the age of 45 years) and late-onset hypertension (onset at the age of 45 years or later) were associated with higher risks for cardiovascular disease (CVD), congestive heart failure, chronic kidney disease, and all-cause mortality, with young-onset hypertension linked to poorer outcomes.
S
StreetInsider.com News source @streetinsider.com · Jan 5

#Hypertension #Healthcare #Innovation

Link Preview
www.streetinsider.com
Idorsia's JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
* Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.
B
Bloomberg Business News source @bloomberg.com · New York City 🇺🇸· Jan 5

#HealthTech #Hypertension #SmartDevices

Link Preview
www.bloomberg.com
Smart Scale Pioneer Debuts $600 Model That Tracks Hypertension Risk
The Body Scan 2 measures more than 60 biomarkers and notifies users that they're at risk of high blood pressure, rather than issuing a definitive diagnosis.
Avatar
Benzinga News source @benzinga.com · Detroit 🇺🇸· Jan 5

#Hypertension #HeartHealth #Pharmaceuticals

Link Preview
www.benzinga.com
Idorsia's JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity NewsletterIdorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.